Cargando…

New twist on the regulation of NKG2D ligand expression

Mostrar otras versiones (1)

Detalles Bibliográficos
Autor principal:	Cerwenka, Adelheid
Formato:	Texto
Lenguaje:	English
Publicado:	The Rockefeller University Press 2009
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2699127/ http://dx.doi.org/10.1084/jem.2009022521809c

Ejemplares similares

New twist on the regulation of NKG2D ligand expression
por: Cerwenka, Adelheid
Publicado: (2009)

New prospects on the NKG2D/NKG2DL system for oncology
por: Ullrich, Evelyn, et al.
Publicado: (2013)

The NKG2D/NKG2DL Axis in the Crosstalk Between Lymphoid and Myeloid Cells in Health and Disease
por: Stojanovic, Ana, et al.
Publicado: (2018)

The Role and Regulation of the NKG2D/NKG2D Ligand System in Cancer
por: Tan, Ge, et al.
Publicado: (2023)

NKG2D/NKG2-Ligand Pathway Offers New Opportunities in Cancer Treatment
por: Frazao, Alexandra, et al.
Publicado: (2019)

Molecular Bases for the Regulation of NKG2D Ligands in Cancer
por: Huergo-Zapico, Leticia, et al.
Publicado: (2014)

Adenovirus serotype 5 E1A sensitizes tumor cells to NKG2D-dependent NK cell lysis and tumor rejection
por: Routes, John M., et al.
Publicado: (2005)

Cutting an NKG2D Ligand Short: Cellular Processing of the Peculiar Human NKG2D Ligand ULBP4
por: Zöller, Tobias, et al.
Publicado: (2018)

Smoking induces expression of ligands of the immune receptor NKG2D
por: Ospelt, Caroline, et al.
Publicado: (2012)

The NKG2D ligand ULBP4 is not expressed by human monocytes
por: Lazarova, Mariya, et al.
Publicado: (2021)

STING-dependent cytosolic DNA sensor pathways regulate NKG2D ligand expression
por: Le Bert, Nina, et al.
Publicado: (2014)

CBP/p300 acetyltransferases regulate the expression of NKG2D ligands on tumor cells
por: Sauer, M, et al.
Publicado: (2017)

Leveraging NKG2D Ligands in Immuno-Oncology
por: Fuertes, Mercedes Beatriz, et al.
Publicado: (2021)

Regulation of NKG2D Stress Ligands and Its Relevance in Cancer Progression
por: Jones, Amber B., et al.
Publicado: (2022)

How Mucosal Epithelia Deal with Stress: Role of NKG2D/NKG2D Ligands during Inflammation
por: Antonangeli, Fabrizio, et al.
Publicado: (2017)

NKG2D(+)CD4(+) T Cells Kill Regulatory T Cells in a NKG2D-NKG2D Ligand- Dependent Manner in Systemic Lupus Erythematosus
por: Yang, Di, et al.
Publicado: (2017)

Redirecting T Cells to Ewing's Sarcoma Family of Tumors by a Chimeric NKG2D Receptor Expressed by Lentiviral Transduction or mRNA Transfection
por: Lehner, Manfred, et al.
Publicado: (2012)

NKG2D discriminates diverse ligands through selectively mechano‐regulated ligand conformational changes
por: Fan, Juan, et al.
Publicado: (2021)

NKG2D ligands mediate immunosurveillance of senescent cells
por: Sagiv, Adi, et al.
Publicado: (2016)

New Insights Into the Regulation of Natural-Killer Group 2 Member D (NKG2D) and NKG2D-Ligands: Endoplasmic Reticulum Stress and CEA-Related Cell Adhesion Molecule 1
por: Hosomi, Shuhei, et al.
Publicado: (2018)

Posttranslational regulation of the NKG2D ligand Mult1 in response to cell stress
por: Nice, Timothy J., et al.
Publicado: (2009)

ADAM10 new selective inhibitors reduce NKG2D ligand release sensitizing Hodgkin lymphoma cells to NKG2D-mediated killing
por: Zocchi, Maria Raffaella, et al.
Publicado: (2015)

Endothelial cells express NKG2D ligands and desensitize antitumor NK responses
por: Thompson, Thornton W, et al.
Publicado: (2017)

Cervical cancer cell lines expressing NKG2D-ligands are able to down-modulate the NKG2D receptor on NKL cells with functional implications
por: Jimenez-Perez, Miriam I, et al.
Publicado: (2012)

CEACAM1 dampens antitumor immunity by down-regulating NKG2D ligand expression on tumor cells
por: Chen, Zhangguo, et al.
Publicado: (2011)

Increased serum NKG2D-ligands and downregulation of NKG2D in peripheral blood NK cells of patients with major burns
por: Haik, Josef, et al.
Publicado: (2015)

Soluble NKG2D ligands impair CD8(+) T cell antitumor function dependent of NKG2D downregulation in neuroblastoma
por: Zhang, Yi, et al.
Publicado: (2023)

NKG2D ligands link oncogenic RAS to innate immunity
por: Ho, Samantha S.W., et al.
Publicado: (2013)

NKG2D and Its Ligands: “One for All, All for One”
por: Zingoni, Alessandra, et al.
Publicado: (2018)

Editorial: The interaction of NKG2D and its ligands in health and diseases
por: Gaudieri, Silvana, et al.
Publicado: (2022)

Secretory pathways generating immunosuppressive NKG2D ligands: New targets for therapeutic intervention
por: Baragaño Raneros, Aroa, et al.
Publicado: (2014)

T Cells Infiltrating Diseased Liver Express Ligands for the NKG2D Stress Surveillance System
por: Huang, Wei-Chen, et al.
Publicado: (2017)

Correction: CD4(+)NKG2D(+) T Cells Exhibit Enhanced Migratory and Encephalitogenic Properties in Neuroinflammation
por: Ruck, Tobias, et al.
Publicado: (2013)

NKG2D Ligands in Tumor Immunity: Two Sides of a Coin
por: Zhang, Jinyu, et al.
Publicado: (2015)

The Biological Influence and Clinical Relevance of Polymorphism Within the NKG2D Ligands
por: Zuo, Jianmin, et al.
Publicado: (2018)

NKG2D Ligands–Critical Targets for Cancer Immune Escape and Therapy
por: Schmiedel, Dominik, et al.
Publicado: (2018)

NKG2D Ligand Shedding in Response to Stress: Role of ADAM10
por: Zingoni, Alessandra, et al.
Publicado: (2020)

MicroRNA-mediated down-regulation of NKG2D ligands contributes to glioma immune escape
por: Codo, Paula, et al.
Publicado: (2014)

Modulation of NKG2D ligand expression and metastasis in tumors by spironolactone via RXRγ activation
por: Leung, Wai-Hang, et al.
Publicado: (2013)

In vitro culture with gemcitabine augments death receptor and NKG2D ligand expression on tumour cells
por: Gravett, Andrew M., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_e98spdsc0639rns9pum5ln8kuh